I can extract side effects

SMA patient groups all over the country became restless on this day.

When Sanqing released the clinical trial announcement before, many parents did not apply immediately for one reason or another.

Some of them have a good family background and have already used Biogen's Nosinagen Sodium Injection, and the child has improved temporarily, so there is no need to worry.

Some have doubts and want to see the results of clinical trials.

Some are too far away from Kunming City, and they can't catch up for a while.

In short, there are so many cases, most of them have not had time to apply, and the first clinical phase has already ended.

At this moment, when they saw the recovery photos of children with experimental diseases posted or reposted by group friends.

I couldn't sit still for an instant.

"Mother Nini, tell me what are the requirements for this application?"

"Yes, how long did it take for your child to heal?"

"It's really just one injection? Just keep going?"

"Great, my baby is finally saved, and I'll apply right away."

Mother Nini replied patiently one by one.

"If the requirements are not high, just bring the case and talk about the basic situation."

"It took a day for the examination, and then the injections. After waiting in the ward for about three days, Nini was able to breathe and eat. She sat up the next day, and she was able to stand up after a few days."

"Anyway, it's really miraculous, it's simply a magic medicine! You guys hurry up and apply for it, try it out sooner!"

Nini's mother's statement was full of joy, and she shared all her experience of participating in clinical trials with her heart and soul.

The parents looked very excited.

Those who were close immediately left for Kunming City, and those who were far away immediately called to inquire about the registration situation.

"Hi, hello, is this Sanqing Pharmaceutical? I am the parent of a child with spinal muscular atrophy. I would like to ask how to apply for clinical trials?"

"Hello, thank you for your call. It is like this. Currently, the number of people in the Phase II clinical trial of this disease is 300. I am sorry that they are all full. You can register your information and apply for the Phase III clinical trial. We will contact you in advance. Yours." The voice on the other end of the phone was very sweet.

"Huh? The registration is full so soon?" The parents were extremely disappointed. After thinking about it, they continued to ask, "How many people are needed for the third period?"

"The specific number of people for the third phase has not yet been determined. According to the usual practice, there should be thousands of people."

"Okay, then you give the registration information now, and I will sign up right away."

Such scenes continue to happen, and the list of clinical trial applications is getting longer and longer.

Since the number of patients with rare diseases is relatively small, the number of people required for clinical trials is also lower than that of common diseases.

SMA is already considered a rare disease with a large number of patients. At least there are tens of thousands of patients. It is not difficult to find patients.

For some diseases, there are only a few hundred people in the world, but only a few dozen people in China. It is extremely difficult to obtain patients.

This time, only 1,000 people are enough for the Phase III clinical trial of SMA, and all clinical trials add up to a total of 1,330 people.

Therefore, the quota for the third phase of the clinical trial was soon full.

Some people are ecstatic when their applications are successful.

Some people are a few steps late and miss the opportunity. They can only continue to wait for the fourth phase of clinical trials, or the drug is on the market.

*****

One month after the clinical trial, Sanqing Group held a press conference.

Officially announced the success of the gene therapy drug for spinal muscular atrophy (SMA), and presented the experimental reports of the first and second clinical phases.

As soon as the news came out, the media in the audience completely boiled!

Both domestic and foreign reporters were instantly flushed with excitement.

"Mr. Wei, is Sanqing going to launch an attack on the field of gene therapy for rare diseases?"

"That's right. The success of this SMA gene drug not only means that SMA patients can get out of the sea of ​​suffering, but also shows that our company has the strength to make a big difference in the field of gene therapy."

Weikang proudly announced: "As we all know, 80% of rare diseases are single-gene genetic diseases, and gene therapy is the fastest way to cure them. , and now, humans have sufficient technical means to save more patients with rare diseases."

"We will continue to use gene therapy to overcome other rare diseases, please wait and see!"

There was thunderous applause at the scene.

After the press conference, Chinese and foreign journalists immediately wrote news reports with great excitement and couldn't wait to publish them on the Internet.

Some reporters even went out of the venue and started writing directly on the car on the return trip.

"Sanqing officially announced to overcome spinal muscular atrophy (SMA) and declared war on other rare diseases."

"Wei Kang, a god-like man, once again created a miracle."

"We have witnessed the real rise of Huaxia's pharmaceutical industry, and Sanqing may become a global medical leader."

"About all that the man has to say, what else is he going to surprise us with?"

"As Sanqing continues to overcome one medical problem after another, we are witnessing a new era."

Netizens were all excited after seeing the news.

"President Wei is amazing, he actually did it."

"Although rare diseases are not common around us, they are extremely painful diseases for patients and their families. Sanqing does not research and develop common diseases, but focuses on the field of rare diseases. This is truly compassionate and unparalleled!"

"Woooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooois

"Sanqing once again saved tens of thousands of patients and families across the country!"

"This is the patron saint of China. As long as we have Sanqing, we will no longer have to take expensive imported medicines!"

On the other side, the SMA family members also shed tears of excitement.

They don't know how many hospitals they went to, how many doctors they consulted, and they traveled all over the country.

Can't get good results.

I can only watch the children step by step towards the abyss of serious illness and death.

In the beginning, the disease was terminally ill and there was no cure!

Later, there was finally medicine.

But they are all imported medicines with exorbitant prices, and the prices of each one are so unattainable!

But start today.

Huaxia also has its own domestic medicine.

It is no longer a terminal illness in human medicine, and there are also medicines within reach.

And the one who gave them hope.

It is Wei Kang.

For a while, countless SMA family members silently erected a monument for Wei Kang in their hearts.

*****

Eagle Country far across the ocean.

The headquarters of Novartis Pharmaceuticals, where the world's top experts in the field of gene therapy gather.

At this moment, watching the news on the big screen, all executives and experts fell silent.

All of them looked as ugly as dead people.

"It's over, the company's stock price is about to hit the limit again." The CEO turned pale and muttered to himself.

"Are we going to lower the price?" an expert couldn't help but say.

Executives, look at me, look at me, none of them made a sound.

After a long time, the CEO of Novartis waved his hand with difficulty: "Of course the price will be lowered, but how much the price will be lowered depends on the decision of the board of directors."

"Thinking about it better, at least our SMA gene drug has already sold 1 billion US dollars. In fact, it has already paid back its capital, and any subsequent sales will be pure profits." The chief financial officer reminded in good faith.

Everyone looked depressed and smiled wryly.

When things come to this, it can only be like this.

The same scene also happened to Biogen and Roche.

The next day, the stock prices of these three pharmaceutical companies fell sharply at the same time, and the stock prices directly fell by 20%.

And they all announced price cuts at the same time, starting from 50%.

The profiteering era of SMA drugs just disappeared.

It was so fast that it caught everyone off guard.

The news spread to the country.

Whether it is netizens or parents of children with SMA.

While looking forward to the launch of Sanqing's new SMA drug.

On the one hand, a new round of guessing drug prices has started.